A.D.V. Pharma India Limited - Due diligence report

A 360° intelligence report on A.D.V. Pharma India Limited: trust score, financial health, credit view, compliance, directors, growth and dis…

2011-01-24 Ujjain, Madhya Pradesh Strike Off Unlisted Active Non-Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

A.D.V. Pharma India Limited — 360° Intelligence Report

Generated from MCA filings & public records
44/100
Trust Score
Caution Indicated

A.D.V. Pharma India Limited is assessed as Caution Indicated with a Trust Score of 44/100. A.D.V. Pharma India Limited is a public limited indian non-government company incorporated in 2011, operating in the Chemicals sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and an unassessed financial risk profile.

Report generated on 18 Oct 2026 from the latest processed filings. A.D.V. Pharma India Limited snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Weak
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
44/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
10/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreNo Data
N/A
No processed financial statements available yet.
Credit Risk ScoreNo Data
N/A
Financial statements needed for a credit view.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

No processed financials
Financial statements are not yet processed for this company. Trend analysis will appear once filings are available.
04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: N/A No Data
  • Financial statements needed for a credit view.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 10/100 Caution Indicated
  • Company status is "Strike Off" - not Active.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2016 - filings overdue.
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
RAGHUVEER SINGH RATHORE 01234567 Director 01/04/2018 6 yrs Approved
RAJENDRA SINGH SISODIYA 01234567 Director 01/04/2018 6 yrs Approved
JAGADISH CHANDRA VYAS 01234567 Director 01/04/2018 6 yrs Approved
DHARMENDRA SINGH SONGARA 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • RAGHUVEER SINGH RATHORE has DIN status "Disqualified by RoC u/s 164(2)".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2016 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 55
Growth signals & trust indicators
Operating for 15+ years.
Financials unavailable - score leans on compliance and governance signals.
Distress signals & risk flags
Statutory filings appear overdue.
Adverse company status: Strike Off.
Compliance score is weak (10/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence34/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • No financials on record - ask for audited statements.
Banker assessment17/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • No filed financials - rely on banking statements and GST data.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view24/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Request management accounts - public filings insufficient.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 12 events
30 Sep 2016
Last AGM held
Annual general meeting
31 Mar 2016
Latest balance sheet
Filed with ROC
20 May 2015
Director ceased
BAGDIRAM DEWADA
12 May 2015
Director appointed
RAJENDRA SINGH SISODIYA (Director)
Director appointed
DHARMENDRA SINGH SONGARA (Director)
28 Sep 2013
Director ceased
JAGADISH CHANDRA VYAS
18 Feb 2013
Director appointed
JAGADISH CHANDRA VYAS (Director)
Director ceased
ANJANA KUWAR
31 Aug 2012
Director ceased
MEHMOOD HUSAIN
14 Jul 2011
Director ceased
BHUPENDRA SINGH HADA
24 Jan 2011
Incorporated
Registered with Roc Gwalior
Director appointed
RAGHUVEER SINGH RATHORE (Director)
10

Key Observations

Auto-generated from the data above
4 active director(s) / partner(s); review board churn before relying on management continuity.
Promoters hold a dominant controlling stake as per the FY 2016 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Mp Grains & Foods (India) Private Limited U15311MP2010PTC023978 Ujjain, Madhya Pradesh
Inspinnoc Technologies Private Limited U93090MP2017PTC043535 Ujjain, Madhya Pradesh
Mtsi Advertising Private Limited U74300MP2013PTC030847 Ujjain, Madhya Pradesh
R.Net Infosystem Private Limited U72200MP2009PTC022703 Ujjain, Madhya Pradesh
Libiya Consumer Products Private Limited U52605MP2018PTC046698 Ujjain, Madhya Pradesh
Avii Farmers Producer Company Limited U01100MP2021PTC055120 Ujjain, Madhya Pradesh
Avocation Facilitator And Consultants Private Limited U74140MP2013PTC030444 Ujjain, Madhya Pradesh
Ujjain Tourism Private Limited U63090MP2019PTC050475 Ujjain, Madhya Pradesh
Informant Tech Services Private Limited U72900MP2015PTC035087 Ujjain, Madhya Pradesh
Shree Markandeyshwar Stone Crusher Private Limited U14290MP2022PTC060270 Ujjain, Madhya Pradesh
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify A.D.V. Pharma India Limited before audits and certifications: compliance score 10/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of A.D.V. Pharma India Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for A.D.V. Pharma India Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 44/100, distress signals and MSME payment-delay disclosures - know whether A.D.V. Pharma India Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for A.D.V. Pharma India Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is A.D.V. Pharma India Limited an active company?

A.D.V. Pharma India Limited has MCA status “Strike Off” with a compliance score of 10/100 (Caution Indicated).

Is A.D.V. Pharma India Limited financially healthy?

Processed financial statements are not yet available for A.D.V. Pharma India Limited, so its financial health is unassessed.

Should I do business with A.D.V. Pharma India Limited?

Its overall Trust Score is 44/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls A.D.V. Pharma India Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 4 active director(s) are on record.

Does A.D.V. Pharma India Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is A.D.V. Pharma India Limited up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 10/100 (Caution Indicated).

Is it risky to lend to A.D.V. Pharma India Limited?

Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.